A review from five studies has found no added benefit of using Daiichi Sankyo’s Radicava (edaravone) and Sanofi’s Rilutek ...
Prospects for Denali Therapeutics' experimental medicine for amyotrophic lateral sclerosis have taken another tumble after the drug generated disappointing biomarker data in a clinical trial. The ...
Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia TA29 26 September 2001 26 September 2001 Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone ...
There’s currently no way to prevent amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, but avoiding smoking, head trauma, and exposure to pesticides or heavy metals may lower the ...
Brainstorm Cell Therapeutics is looking for financial and corporate partners to help complete the development and launch of revolutionary neurodegenerative disease treatments. Neurodegenerative ...
The analysis included five studies comprising 548 patients, of whom 39.4% received combination therapy. Credit: Faizal Ramli / Shutterstock.com A systematic review and meta-analysis evaluating whether ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that results in the death of nerve cells called motor neurons in the brain and spinal cord. These neurons control voluntary ...
HAYWARD, Calif.-LAWFUEL – The Legal Newswire – IMPAX Laboratories, Inc. (OTC:IPXL) today announced that the U.S. District Court for the District of Delaware has ruled that Aventis Pharmaceutical’s ...
Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease characterized by the progressive loss of motor neurons, nerve cells that control the voluntary muscles. This leads to overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results